Ketoprofen

ANDA 73515, held by Teva. Ketoprofen.

As of Nov 15, 2026, ANDA 73515 (Ketoprofen), held by Teva, was first approved by FDA on Dec 22, 1992, with 10 approved supplements and 0 published complete response letters.

First approved: Dec 22, 1992
Supplements approved: 10
Complete response letters: 0

Approvals and New Uses

The original application and every efficacy supplement, newest first; all 11 submissions below

Date	Submission	Status	Documents
Dec 22, 1992	Original application	Approved	None posted

Products

1 strengths and forms

Product	Active ingredient	Marketing
Ketoprofen25MG · capsule;oral	Ketoprofen	Discontinued

All 11 submissions, including labeling and manufacturing supplements


Mar 26, 1999	Supplement 12Manufacturing	Approved	None posted
Jul 14, 1998	Supplement 11Manufacturing	Approved	None posted
Mar 17, 1998	Supplement 8Labeling	Approved	None posted
Dec 10, 1997	Supplement 10Manufacturing	Approved	None posted
May 13, 1997	Supplement 9Manufacturing	Approved	None posted
Mar 14, 1997	Supplement 7Manufacturing	Approved	None posted
Mar 14, 1997	Supplement 6Manufacturing	Approved	None posted
Feb 16, 1995	Supplement 3Manufacturing	Approved	None posted
Sep 6, 1994	Supplement 2Manufacturing	Approved	None posted
Jul 15, 1994	Supplement 1Manufacturing	Approved	None posted
Dec 22, 1992	Original application	Approved	None posted

Identifiers

Application: ANDA 73515
Drugs@FDA: Overview at FDA
Company: Teva Pharmaceutical Industries

Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters